DCK 抗体
(Deoxycytidine Kinase (DCK))
Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity. [provided by RefSeq, Jul 2008].
recommended
recommended
recommended
DCK 适用: 人, 小鼠, 大鼠 WB, IF, IP, IHC (p), ICC 宿主: 兔 Polyclonal unconjugated
DCK 抗体 by Grade
Find DCK 抗体 with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
DCK 抗体 by 抗体来源
Find DCK 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
DCK 抗体 by 克隆形成能力
Find available monoclonal or polyclonal DCK 抗体. Click on a link to go to the corresponding products.
DCK 抗体 by 克隆
Find DCK 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
DCK 抗体 by 标记
Find DCK 抗体 with a specific conjugate such as Biotin, FITC, HRP. The conjugates listed below are among those available. Click on a link to go to the corresponding products.
Popular DCK 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
WB, IHC, IF, IHC (p), FACS
Validations
- (7)
Cat. No.
ABIN1497773
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IHC (p), FACS
Validations
- (9)
Cat. No.
ABIN1497775
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, IF, IP, IHC (p), ICC
Validations
- (6)
Cat. No.
ABIN2856517
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IF, IP, IHC (p), ICC
Validations
- (8)
Cat. No.
ABIN2855484
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IF
Validations
- (1)
- (4)
Cat. No.
ABIN514902
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IF
Validations
- (5)
Cat. No.
ABIN3022558
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IP
Validations
- (4)
Cat. No.
ABIN514893
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
WB, IF, IP, IHC (p)
Validations
- (2)
- (4)
Cat. No.
ABIN391125
Quantity
400 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IF
Validations
- (3)
Cat. No.
ABIN514897
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC, IHC (p)
Validations
- (2)
Cat. No.
ABIN299601
Quantity
50 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, IF
Validations
- (2)
Cat. No.
ABIN514889
Quantity
50 μg
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, IHC, IF, IC
Validations
- (3)
Cat. No.
ABIN7306024
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, IHC
Validations
- (1)
Cat. No.
ABIN7149696
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, ELISA
Validations
- (1)
Cat. No.
ABIN7240775
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Dog, Guinea Pig, Hamster, Human, Monkey, Mouse, Rabbit, Rat
Application
WB
Validations
- (1)
Cat. No.
ABIN6743592
Quantity
100 μL
Datasheet
Datasheet
Latest Publications for our DCK 抗体
: "Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity." in: BMC cancer, Vol. 18, Issue 1, pp. 466, (2018) (PubMed).: "Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer." in: Acta oncologica (Stockholm, Sweden), Vol. 55, Issue 3, pp. 286-96, (2016) (PubMed).
: "The effects of forodesine in murine and human multiple myeloma cells." in: Advances in hematology, Vol. 2010, pp. 131895, (2010) (PubMed).
: "Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity." in: Blood, Vol. 113, Issue 10, pp. 2145-53, (2009) (PubMed).
: "The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase." in: Cancer research, Vol. 69, Issue 11, pp. 4567-72, (2009) (PubMed).
: "Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma." in: Laboratory investigation; a journal of technical methods and pathology, Vol. 88, Issue 7, pp. 773-84, (2008) (PubMed).
: "Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants." in: The Journal of pharmacology and experimental therapeutics, Vol. 323, Issue 3, pp. 935-45, (2007) (PubMed).
: "Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells." in: Molecular and cellular biochemistry, Vol. 231, Issue 1-2, pp. 173-7, (2002) (PubMed).
Aliases for DCK 抗体
deoxycytidine kinase (DCK) 抗体deoxycytidine kinase (dck) 抗体
deoxycytidine kinase, gene 2 L homeolog (dck.2.L) 抗体
deoxycytidine kinase, gene 2 (dck.2) 抗体
deoxycytidine kinase (Dck) 抗体
Deoxycytidine kinase (FPV059) 抗体
Deoxycytidine kinase (FPV151) 抗体
deoxycytidine kinase, gene 1 L homeolog (dck.1.L) 抗体
dck 抗体
DCK 抗体
dck1 抗体
wu:fc15f06 抗体
zgc:101771 抗体
您还需要查找其他产品吗？
You are here:
